首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   228522篇
  免费   20637篇
  国内免费   8118篇
耳鼻咽喉   1305篇
儿科学   4960篇
妇产科学   2904篇
基础医学   39631篇
口腔科学   4390篇
临床医学   15776篇
内科学   36577篇
皮肤病学   3961篇
神经病学   17301篇
特种医学   4594篇
外国民族医学   61篇
外科学   16808篇
综合类   29633篇
现状与发展   32篇
预防医学   12470篇
眼科学   2586篇
药学   31201篇
  24篇
中国医学   9074篇
肿瘤学   23989篇
  2024年   548篇
  2023年   3318篇
  2022年   6857篇
  2021年   8742篇
  2020年   7209篇
  2019年   9954篇
  2018年   9308篇
  2017年   8382篇
  2016年   7828篇
  2015年   9556篇
  2014年   14073篇
  2013年   15117篇
  2012年   13817篇
  2011年   16063篇
  2010年   13991篇
  2009年   13843篇
  2008年   12414篇
  2007年   12065篇
  2006年   10884篇
  2005年   9100篇
  2004年   7254篇
  2003年   6394篇
  2002年   5019篇
  2001年   4288篇
  2000年   3549篇
  1999年   3162篇
  1998年   2747篇
  1997年   2460篇
  1996年   2164篇
  1995年   1836篇
  1994年   1610篇
  1993年   1312篇
  1992年   1147篇
  1991年   1011篇
  1990年   817篇
  1989年   692篇
  1988年   592篇
  1987年   528篇
  1986年   527篇
  1985年   1100篇
  1984年   1170篇
  1983年   796篇
  1982年   854篇
  1981年   665篇
  1980年   608篇
  1979年   485篇
  1978年   339篇
  1977年   282篇
  1976年   267篇
  1975年   187篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
931.
1. In orefer to develop a simple, efficient system for the highlvel expression of dopamine recetors in eukaryotic cells, we have studied the effects of n-butyrate on the expression of rat D1A dopamine receptor cDNA in mouse fibroblast LTK- cells as compared with those of n-butyrate on endogenous D1 receptor levles in opossum kidney cells.
2. In the transfected LTK- cell mebranes with pRc/CMVD1A receptor cDNA, a selective D1 dopamine antagonist, [3H]-SCH 23390, exhibited a Kd of 0.9 ± 0.1 nmol/L and a Bmax of 0.35 ± 0.05 pmol/mg protien (n = 5).
3. Addtion of n-butrate (2–10 mmol/L) to the culture medium for 48h dose-dependently increased the D1A receptor level up to 1.5 ± 0.3 pmol/mg protien (n = 7), although the Kd values were not affected. The increase in receptor level was accompanined by an elevation of selective D1 agoinist-induced adenyly cyclase activity.
4. In contrast, n-butyrate treatment (2–10 mmol/L) did not affect either endogenous D1 receptor levels or fendoldopmainduced adenylyl cyclase activity in possum kidney cells.
5. These results sugges n-butyrate is a sueful tool for obtaining high-level expression of D1A dopamine receptor cDNA in mouse fibroblast LTK- cells.  相似文献   
932.
Memantine (1-amino-3,5-dimethyladamantan) was tested as an antagonist of N-methyl-d-aspartate (NMDA) receptors on cultured superior collicular and hippocampal neurones using the patch clamp technique and its actions were compared to those of Mg2+ ions, ketamine, dextrorphan, dextromethorphan, phencyclidine and dizocilpine (MK-801). Memantine (2–33 μM) concentration-dependently antagonized responses to NMDA 100 μM with an IC50 of 2.92 ± 0.05 μM. In contrast, current responses to (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (l-AMPA 50–100 μM) and γ-amino butyric acid (GABA 10 μM) were unaffected by Memantine 8 μM. Memantine 8 μM caused a non-parallel shift of the NMDA concentration-response curve to the right in a manner indicative of uncompetitive open channel block. The effects of memantine were similar to ketamine in that both antagonists were weakly use- and strongly voltage-dependent. In contrast, MK-801, phencyclidine and dextrorphan showed much slower kinetics that was reflected in their marked use- and weaker voltage-dependency. The antagonistic effects of memantine were not reversed by increasing concentrations of glycine (0.1–100 μM) ruling out the possibility of an interaction of memantine with the strychnine-insensitive glycine modulatory site associated with the NMDA receptor-channel complex. Memantine (1–100 μM) also selectively antagonized responses to NMDA (40 μM) in the cortical wedge preparation with IC50 of 12.9 ± 1.5 μM.  相似文献   
933.
Diethyl 1-cyclopropyl-5,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3,6-dicarboxylate 4 as a key-intermediate was synthesized via the Dieckmann reaction. The reaction of 4 with nucleophiles proceeded regioselectively at C-5. Facile cyclization between the C-5 and C-6 side chains of the resulting products gave novel pyrroloquinolones 10 and 12 and pyrazoloquinolones 15. They were converted into a series of cyclic amino-substituted pyrroloquinolones 17–21 and pyrazoloquinolones 22–24, and their in vitro antibacterial activities were tested. 1H-Pyrrolo[2,3-f]quinolone 17a and 2H-pyrrolo[3,4-f]quinolone 21a exhibited a potent in vitro antibacterial activity.  相似文献   
934.
健康成年金黄仓鼠腹腔内接种PVH-1(5×106pfu),FCM动态检测肝细胞DNA周期动力学变化,结果显示:PVH-1接种后处于G0+G1期的肝细胞与对照组动物相比无显著差异。S期肝细胞在第3天显著高于对照组动物(P<0.05),且在第7天时仍呈上升趋势,第14天到30天趋于正常水平。G2+M期肝细胞在PVH-1接种后第30天升高(P<0.05)。结果提示,动物在PVH-1接种后第3到第7天是病毒在肝细胞中的复制高峰,并阻滞仓鼠处于S期肝细胞分裂进入G2+M期,但是这种阻滞作用较短暂、并可逆,在PVH-1接种后14~30天自然消失。  相似文献   
935.
5-HT1A receptor agonists: recent developments and controversial issues   总被引:4,自引:0,他引:4  
During the last decade, serotonin (5-HT)1A receptors have been a major target for neurobiological research and drug development. 5-HT1A receptors have been cloned and a variety of selective agonists, such as the aminotetraline 8-OH-DPAT and the pyrimidinylpiperazine ipsapirone, have become available. Demonstrations of apparent intrinsic activity of these ligands at 5-HT1A receptors, however, depend highly on the particular assay system. This may be due to the possible existence of receptor subtypes and to assay (or brain region)-dependent differences in receptor reserve and the nature of receptor-effector coupling. Nevertheless, the apparent intrinsic activity of 8-OH-DPAT seems to be higher (although possibly not yet maximal) than that of the pyrimidinylpiperazines. In the brain, 5-HT1A receptors are located presynaptically as somatodendritic receptors on 5-HT neurons and postsynaptically in particular limbic and cortical regions. Although it is generally accepted that presynaptic 5-HT1A receptors control 5-HT neuronal activity, recent evidence suggests an additional role of postsynaptic 5-HT1A receptors in cortex as part of a negative feedback loop. Anxiolytic and antidepressive properties of selective 5-HT1A receptor agonists have now been confirmed by clinical studies. Although it is well established that the latter properties depend on theagonistic activity of these compounds, theoptimal level of intrinsic activity is still a matter of debate and may be dependent on the clinical indication. Such compounds may also have antiaggressive effects, and possibly anticraving effects (manifested by their alcohol intake-reducing effects in dependent animals), but the specificity of these so-called anti-impulsivity effects is still controversial and not yet tested clinically. Anticataleptic, antiemetic and neuroprotective properties have been demonstrated in different species. Behavioral studies on the mechanisms underlying the anxiolytic and antidepressive effects have examined the relative contribution of pre-and postsynaptic 5-HT1A receptors by means of local cerebral application and lesion techniques. Most evidence points towards a critical involvement of presynaptic receptors in the anxiolytic effects of 5-HT1A receptor agonists (although a possible contribution of postsynaptic receptors cannot be excluded). With regard to the antidepressive properties, a case can be made for the reverse; i.e., a strong involvement of postsynaptic receptors and a questionable contribution of presynaptic receptors. However, as the therapeutic effects of those 5-HT1A receptor (partial) agonists which have been tested clinically require repeated administration, attention has been directed increasingly towards chronic studies. These studies have shown that a number of electrophysiological, biochemical, behavioral and endocrinological 5-HT1A receptor-related events adapt differentially to repeated or sustained administration. Thus, several hypotheses accounting for the delayed onset of action have been advanced. Among these, time-dependent downregulation /desensitization of eitherpre- orpostsynaptic 5-HT1A receptors, or cortical 5-HT2 receptors have received much attention. However, these hypotheses have their weaknesses, and it is argued thatfunctional sensitization of particular postsynaptic 5-HT1A receptor-mediated events remains a valuable alternate hypothesis. Basic research on the role of 5-HT1A receptors in psychopathology and in the therapeutic effects of clinically effective therapeutics, as well as on the mechanism of action of 5-HT1A receptor ligands, will enable rational design of ligands with particular profiles of intrinsic activity at different 5-HT1A receptor populations, and may contribute to a more efficient treatment of a multiplicity of brain disorders.  相似文献   
936.
P物质及其受体在慢性胰腺炎组织的表达和临床意义   总被引:3,自引:1,他引:2  
目的 了解P物质及其受体NK-1R在正常胰腺和慢性胰腺炎中的表达,探讨它们与慢性胰腺炎时疼痛发生的关系。方法 25个慢性胰腺炎标本取自慢性胰腺炎手术,男性18例,女性7例,正常胰腺组织取自20个器官捐献者,男性11例,女性9例。应用实时定量逆转录整合酶链反应(RT-PCR)技术,检测正常胰腺和慢性胰腺炎组织中P物质和NK-1R的mRNA水平,应用Western blot技术检测NK-1R的蛋白水平,应用免疫组织化学方法进行NK-1R的组织学定位。将P物质及其受体NK-1R mRNA水平与疼痛的程度,发作频率和病程进行分析,寻找其中的相关性。结果 与正常胰腺相比,慢性胰腺炎组织中P物质和NK-1R mRNA和蛋白都过度表达,NK-1RmRNA水平与疼痛的程度,发作频率和病程明显相关。免疫组化检查显示,NK-1R的表达主要位于胰腺腺泡,胰腺导管,神经纤维和炎性细胞。结论 慢性胰腺炎组织中P物质和NK-1R的表达水平都明显上调,扰乱了神经激肽的作用环节,NK-1R的过度表达与疼痛发生有关。  相似文献   
937.
目的:探讨安桃乐(ENTONOX)气体吸入对分娩镇痛及母婴结局的影响。方法:将181名无产科或内科合并症的住院产妇随机分成两组,一组由家属全程陪护,另一组由家属全程陪护+安桃乐气体吸入,观察两组产妇的镇痛效果、产程进展、分娩方式、新生儿Apgar评分情况、产后出血量。结果:ENTONOX吸入对分娩镇痛有效率达98.2%,显效率达80.7%,对产程进展有促进作用,对分娩方式、围产儿结局、产后出血量无显著性差异。结论:ENTONOX吸入镇痛是一种安全、有效的辅助分娩技术,作用迅速、费用低廉,是产妇乐意接受的镇痛方法。  相似文献   
938.
BACKGROUND: Asymmetrical dimethylarginine (ADMA) is capable of inhibiting nitric oxide synthase enzymes, whereas symmetrical dimethylarginine (SDMA) competes with arginine transport. The potential role of inflammation in the metabolism of ADMA has been elucidated in an in vitro model using tumour necrosis factor-alpha, resulting in a decreased activity of the ADMA-degrading enzyme dimethylarginine dimethylaminohydrolase (DDAH). The kidney probably plays a crucial role in the metabolism of ADMA by both urinary excretion and degradation by DDAH. We aimed to further elucidate the role of the kidney in a rat model under basal conditions and during endotoxaemia. METHODS: Twenty-five male Wistar rats weighing 275-300 g were used for this study. The combination of arteriovenous concentration differences and kidney blood flow allowed calculation of net organ fluxes. Blood flow was measured using radiolabelled microspheres according to the reference sample method. Concentrations of ADMA, SDMA and arginine were measured by high-performance liquid chromatography. RESULTS: The kidney showed net uptake of both ADMA and SDMA and fractional extraction rates were 35% and 31%, respectively. Endotoxaemia resulted in a lower systemic ADMA concentration (P = 0.01), which was not explained by an increased net renal uptake. Systemic SDMA concentrations increased during endotoxaemia (P = 0.007), which was accompanied by increased creatinine concentrations. CONCLUSIONS: The rat kidney plays a crucial role in the regulation of concentrations of dimethylarginines, as both ADMA and SDMA were eliminated from the systemic circulation in substantial amounts. Furthermore, evidence for the role of endotoxaemia in the metabolism of dimethylarginines was obtained as plasma levels of ADMA were significantly lower in endotoxaemic rats.  相似文献   
939.
MMP-9和TIMP-1在实验性肺气肿大鼠肺组织中的表达及其意义   总被引:2,自引:0,他引:2  
目的研究基质金属蛋白酶(MMP-9)及其组织抑制因子(TIMP-1)在弹性蛋白酶所致肺气肿大鼠肺组织中的表达.方法雄性Wistar大鼠20只,随机分为两组:正常对照组和肺气肿模型组,每组10只.模型组大鼠气管内滴入弹性蛋白酶复制肺气肿模型.25d后,观察各组大鼠肺组织的病理改变,免疫组化方法观察肺组织MMP-9和TIMP-1中的蛋白表达情况.结果肺气肿模型组MMP-9和TIMP-1的表达与正常对照组相比明显增强(P<0.01),且MMP-9/TIMP-1比值失衡.结论MMP-9/TIMP-1失衡在肺气肿形成中起重要作用.  相似文献   
940.
目的探讨高糖不同浓度刺激或抑制剂对肾小球系膜细胞表达细胞周期负控蛋白P27的影响.方法不同浓度高糖(5.5 mmol/L和25mmol/L、内皮素-1(10-7mol/L)、白介素-13(10 ng/ml和100 ng/ml)作用于培养的系膜细胞.流式细胞仪检测系膜细胞P27表达水平.结果5.5mol/L浓度组在不同时间P27表达为5.10±0.94和3.84±0.81,较对照级明显降低(P<0.001),而25 mmol/L浓度组在不同时间P27表达为26.82±3.15和30.88±3.68,较对照组明显升高.内皮素-1刺激14 h和18 h后P27的表达分别为14.76±1.49和12.18±1.30,与对照组比较有明显差异(P<0.05,P<0.05).IL-13 10 ng/ml浓度组和100 ng/ml浓度组P27表达为46.74±3.52和23.8±2.56,对对照组比较有明显差异(P<0.001,P<0.05),不同浓度组之间有显著差异(P<0.01).结论细胞周期调节负控蛋白P27在调节系膜细胞增殖过程中起重要作用.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号